Lv1
90 积分 2023-09-19 加入
Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High‐Glucose Environment by Activating the AMPK/PGC‐1α/SIRT3 Signalling Pathway
3天前
已完结
More Disease, Fewer Arrhythmic Events: A Competing-Risk Signal for SGLT2 Inhibitors in ICD Recipients
3天前
已完结
Impact of empagliflozin and dapagliflozin on sudden cardiac death: A systematic review and meta-analysis of adjudicated randomized evidence
3天前
已完结
The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial
3天前
已完结
SGLT2 inhibitors: Do they have antiarrhythmic properties?
3天前
已完结
Antiarrhythmic potential of SGLT2 inhibitors: Mechanistic insights and clinical evidence
3天前
已完结
More Disease, Fewer Arrhythmic Events: A Competing‐Risk Signal for SGLT2 Inhibitors in ICD Recipients
19天前
已完结
Prognostic Impact of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers on Recurrent Ventricular Tachyarrhythmias and Implantable Cardioverter–Defibrillator Therapies
4个月前
已完结
Role of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias
6个月前
已完结
Ventricular Arrhythmias and Heart Failure
6个月前
已完结
皖公网安备34019202002308
